肿瘤免疫治疗——遇上最好的时代

Cancer Immunotherapy Comes of Age

肿瘤免疫治疗被称为继手术、放疗、化疗后第4种肿瘤疗法,其可激活特异性、重要的免疫细胞,直接靶向性攻击癌症细胞,具有较高的疗效和安全性,是目前全球肿瘤治疗研究的热点。报告采用文献调研、数据库检索、数据统计与分析等定性定量研究方法,从市场预测、发展历程、国内外企业布局情况等方面对肿瘤免疫治疗药物领域进行多角度、多层次的分析,旨在为相关企业明确发展方向、确定产品研发思路及制定市场策略提供线索和参考。

As the fourth cancer therapy following surgery, chemotherapy, and radiotherapy, immunotherapy activates specific, important immune cells to directly target the cancer cells. Due to its high efficacy and safety, immunotherapy has become a hot topic in cancer research worldwide. Based on qualitative and quantitative research methods including literature research, database retrieval and data statistics, cancer immunotherapy was analyzed in this report at multiple levels from the aspects of market forecast, development progress and industrial layout at home and abroad, so as to provide references for pharmaceutical enterprises to decide development direction, determine research approaches and formulate market strategy.